We are pleased to publish the February issue of the @AJPCardio sciencedirect.com/journal/am… While several papers here carry forward work initiated last year, this issue reflects on practical reality, an intentional focus for us at the journal moving forward, reflected in the new papers. Cardiovascular prevention management entered an era of lower thresholds, broader eligibility, and more intensive therapy. Yet implementation remains uneven and frequently constrained by cost, access, and therapeutic inertia. Its time to bring that in focus... This direction is visible across the issue 1. Guideline refinement. #AnnMarieNavar and team examines the projected implications of the 2025 AHA/ACC blood pressure recommendations quantify how eligibility and treatment intensity may shift across populations, moving beyond recommendations with operational impact 2. Economic sustainability. As wide range of therapies for patients with diabetics become more common, affordability becomes central. @rohan_khera economic analyses and @MOSSIALOS editorial underscore the need to balance clinical benefit with long-term scalability 3. Subclinical imaging. @miguelcainzos23 shows emerging strategies around atherosclerosis imaging highlight its expanding role in outreach, risk communication, and treatment engagement, @MichaelJBlaha discussing how imaging can be integrated into prevention frameworks rather than used as a modifier alone. 4. Equity and representation. #DianeBrisson paired original research with @DrMarthaGulati @Nishant_ShahMD editorial commentary on sex representation in trials reinforce that generalizability should be central and non-negotiable 5. Expanding risk constructs. Contributions spanning cardiometabolic risk, pregnancy-related cardiovascular health, and environmental determinants reflect a broader understanding of prevention as multidimensional. Beyond papers....we are thinking deeply of the future for our journal in its role beyond being a reflection of what's the latest in CV prevention science... In this issue, @DrMichaelShapir @ASPCardio President’s message highlights the alignment between ASPC and AJPC for advancing prevention science while strengthening education and implementation. A society shapes practice, where our journal will shape the dialogue. When aligned deliberately, we both will accelerate responsible adoption. @CarlosVergaraMD a truly rising superstar, details creation of AJPC Academy for structured approach to reviewer development & scholarly engagement. Sustained progress also depends on intellectual infrastructure to build the future talent pipelines Taken together, this issue reflects a field transitioning from evidence accumulation toward delivery refinement & capacity building. As the world of CV prevention science advances, the next phase will depend on how effectively we integrate these advances into workflows that are practical, equitable, and sustainable Grateful to our authors, reviewers, and editorial team for making this possible. Khurram @CardioNerds @CiccaroneCenter @DeBakeyCVedu @HMethodistCV @RonBlankstein @Sadeer_AlKindi